Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Special Hospital in Bethesda, MD
NPI: 1396917332HQ Phone
Get M.D., PH.D. Chia's Phone Numberphone_androidMobile
Get M.D., PH.D. Chia's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
2009 - 2019
MD State Medical License
National Board of Physicians and Surgeons
Internal Medicine
National Board of Physicians and Surgeons
Medical Oncology
National Institutes of Health Clinical Center
Fellowship • Medical Oncology
2005 - 2008
Wake Forest School of Medicine
school.wakehealth.edu
Medical School
Until 2002
Authors: Rajesh Tota-Maharaj, Gurpreet Dhaliwal, Jean Ballweg, Christopher Barnett, Brian Moyers, Diana Dean, Peter Mccullough, Philip Lavallee, Jinoos Yazdany, Richard Williams
Journal: JACC Cardiovasc Interv
Phase Ib study of drozitumab combined with cetuximab (CET) plus irinotecan (IRI) or with FOLFIRI ± bevacizumab (BV) in previously treated patients (Pts) with metastatic colorectal cancer (mCRC).
Authors: Baron AD, O'Bryant CL, Choi Y, Ashkenazi A, Royer-Joo S, Portera CC
Publication Date: 2011-05
Lead Sponsor: Genentech, Inc.
Intervention / Treatment: DRUG: gemcitabine, DRUG: GDC-0425
Lead Sponsor: Genentech, Inc.
Intervention / Treatment: DRUG: GDC-0917
Lead Sponsor: Genentech, Inc.
Intervention / Treatment: DRUG: bevacizumab, DRUG: FOLFOX regimen, DRUG: dulanermin